PIK3CA and neoplasm: Although the direct action of pan PI3K or isoform-specific PI3K inhibitors on stromal fibroblasts has not yet been tested in PDAC, modulation of PI3K signaling could likely impact several aspects of tumor–stroma interaction and give us a more robust rationale to target this signaling node in PDAC in future years.